CivicKnodeCivicKnowA project of CivicKnode
Sign in

SB 669

VetoedCrossfile HB 1095
Add to calendar

Public Health - Prescription Drug Affordability Board and Fund

Sponsor: PresidentCommittee: FinanceSubject: Public HealthStatus: Vetoed by the Governor (Policy) (as of Nov 6, 2020)

What this bill does

Official synopsis

Repealing certain provisions of law requiring the Prescription Drug Affordability Board to determine a certain funding source by December 31, 2020; requiring the Board to assess and collect a certain fee from certain persons in a certain manner; requiring the Board to calculate a certain fee in a certain manner; requiring entities assessed a certain fee to pay a the fee on or before October 1 each year; establishing the Prescription Drug Affordability Fund as a special, nonlapsing fund; etc.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (9)

MGA witness list
FAV 8FavorableINFO 1Information only
PositionWitnessOrganizationTestimony
FAVBresnahan, TammyAARP MDOral + Written (PDF)
FAVRenfrew, MeganMHCCWritten (PDF)
FAVDeMarco, VincentlobbyistMaryland Citizens Health InitiativeOral + Written (PDF)
FAVRansom, GeneMedChiWritten (PDF)
FAVMitchell, VanPrescription Drug Affordability BoardOral + Written (PDF)
FAVMcGarvie Crowley, BettyUULMMWritten (PDF)
FAVBlendy, NicholasIndividualWritten (PDF)
FAVPresident, PresidentIndividualPosition only
INFODiLoreto, MattHealthcare Distribution AllianceWritten (PDF)

Organizations on record

Registered lobbyists who testified

FAVDeMarco, VincentMaryland Citizens Health InitiativeRegistered for: Maryland Citizens' Health Initiative, Inc.; Maryland Citizens' Health Initiative Education Fund